Congratulations to the amazing team Prime Medicine for their tremendous work to move prime editing from an exciting academic discovery into a product ready for clinical trials to help patients with chronic granulomatous disease

We are so excited to work with Kevin and his team on a completely novel approach to cancer therapy with the potential to help patients with cancer

Great interview podcast with GV partner and friend Tom Hulme

Congrats to the entire @agiospharma team for the incredible progress and the plenary talk at #EHA2024

Welcome to the team elena sakach - excited to be working with you

Congratulations to Mike Fried and the entire team for a fabulous season

Huge congrats to the entire Agios team for a fabulous deal with Royalty Pharma

Congratulations to everyone Agios on the second positive phase 3 trial in thalassemia- terrific news for patients

Congrats to the Santa Ana team and to Brendan Bulik-Sullivan for leading the round for GV

Incredibly proud of both the Agios and Servier Pharmaceuticals teams- changing the landscape for patients with IDH glioma- great day for these patients

Thrilled to be working with this amazing group of people and excited by the impact we are and will be making in some many important areas in digital and healthcare.

Exciting collaboration with ⁦Bristol Myers Squibb⁩ to develop suite of new medicines- congratulations to ⁦Prime Medicine⁩ and ⁦Bristol Myers Squibb⁩ investors.primemedicine.com/news-releases/…

Congratulations to Sarah and the entire Agios team for this great accomplishment

Congratulations to Sarah and the entire Agios team

I am so proud of the entire Agios team on another important clinical milestone and proud of the impact we will have on children with this disease that currently has no treatment options other than supportive care.

David- congratulations on such a well deserved recognition for the tremendous impact these medicines will make on patients around the world

Congratulations to Sek Kathiresan MD and the entire Verve team- will be exciting to see the programs continue to move forward for the patients at need

Congratulations to the entire Agios team- excited for the patients who will benefit

Congratulations to the Pelage Pharma team and the GV is excited to welcome Arch Ventures into the syndicate

Congrats to the awesome teams Servier and Agios for the development of vorasidenib for patients with Glioma